Literature DB >> 19836638

Recurrent syncope in elderly patients and tilt test table outcome: the role of comorbidities.

F Vetta1, S Ronzoni, M Costarella, C Donadio, L Battista, G Renzulli, G Gentile, S M Zuccaro.   

Abstract

Syncope is a common disorder that can lead to serious consequences in the elderly. Tilt-test is a safe, useful specific tool to investigate recurrent syncope also in the elderly. Comorbidities and medication use, widely present in elderly patients, affecting the hemodynamic response, can influence the tilt-test outcome. The aim of this study was to evaluate the influence of these confounding factors on tilt-test results in elderly patients with recurrent syncope. We included in this study a consecutive group of 87 patients>75 years (82.1+/-4.3 years) with unexplained syncope. They underwent passive upright tilt-test. Heart rate an blood pressure were recorded using non-invasive devices. The patients were classified according to the modified Vasovagal Syncope International Study (VASIS). Comorbidities were measured with the geriatric index of comorbidities (GIC), which is a composite score taking into account both the number of diseases and their severity as measured by Greenfield's IDS. The tilt-test was positive in 22 patients. There were no significant differences in clinical characteristics, and medication use between the tilt-test negative and positive patients, except for the GIC score (1.12+/-0.5 vs. 2.42+/-0.48; p=0.001) and for a reduced number of medications in the former group (5.7+/-3.1 vs. 8.2+/-2.4; p=0.001). This study suggests that comorbidities and the number of medications could influence tilt test outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19836638     DOI: 10.1016/j.archger.2009.09.034

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  1 in total

1.  Patients with syncope in a German emergency department: description of patients and processes.

Authors:  Sebastian Güldner; Viktoria Langada; Steffen Popp; Hans Jürgen Heppner; Harald Mang; Michael Christ
Journal:  Dtsch Arztebl Int       Date:  2012-01-27       Impact factor: 5.594

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.